Mode
Text Size
Log in / Sign up
N/A Completed N=86 Treatment

Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead

Source: ClinicalTrials.gov NCT00763698 ↗
Enrolled (actual)
86
Serious AEs
4.7%
Results posted
Nov 2011
Primary outcomePrimary: Freedom From Left Ventricular Lead-related Complications — 100 percent of participants

Summary

This is a prospective, multi-center non-randomized clinical study to evaluate the safety and efficacy of the QuickFlex Micro Model 1258T left ventricular lead in a heart failure patient population. The study will be conducted at a maximum of 20 investigational centers located in the United States and a total of 68 patients will be enrolled.

Outcome Measures

OutcomeResultp-value
PRIMARY
Freedom From Left Ventricular Lead-related Complications
100 —
PRIMARY
Percentage of Successful Left Ventricular Lead Implants
94 —
PRIMARY
Left Ventricular Bipolar Pacing Capture Threshold (Volts)
1.1 —

Eligibility Criteria

Inclusion Criteria

  • Approved indication for CRT-D system

Exclusion Criteria

  • Previous cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 3 months of enrollment
  • Previous left ventricular (LV) lead implant
  • Have had a heart attack, unstable angina or cardiac revascularization (percutaneous transluminal coronary angioplasty (PTCA),coronary artery bypass grafting (CABG), Stent) within 40 days prior to enrollment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00763698). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search